Common GLP-1 Medications Explained Several GLP-1 medications are approved for use in the United States, including: Ozempic (semaglutide) Wegovy (also semaglutide, prescribed for weight management), Trulicity (dulaglutide) Victoza (liraglutide) These are available as weekly or daily injections and have seen a surge in demand, as new studies validate not just their effectiveness for diabetes but also for aiding weight loss
As William Miller, CEO of Villya Pharmaceuticals and inventor of our patented technology (WO 2025/064695 A1), I appreciate the discussion around Lillys groundbreaking work in the GLP-1 space
Patients who experienced nausea, vomiting, diarrhea, or dehydration during the treatment were at the highest risk of acute kidney injury, with volume depletion being the suspected link
Understanding the nuances of insurance policies, including eligibility requirements and potential hurdles, is essential for patients seeking this medication
[] Early intervention, particularly through intensive glucose control, has long-term benefits for patients with diabetes, a phenomenon known as the legacy effect
